Emilie Vinolo retweeted
📣 VHIO will be the new Chair of @EurOPDX, as presented during the annual meeting celebrated in Paris, where we have discussed and presented the latest advances in Patient-Derived Models.
Goretti Mallorquí has taken over as the new EurOPDX manager. Thank you, @MaxVBorsani and @seedingscience for your commitment and work during all these years!
Emilie Vinolo retweeted
Not heard about our 3rd Workshop in June yet?
It's your lucky day! Registration and abstract submission deadline is extended by 1 week, til 27 May.
Don't wait any longer to register and start preparing your abstract to share your work using patient-derived models in oncology.
Registration to the 3rd EurOPDX Workshop is OPEN!!
Join us on 27-29 June on the shores of the North Sea in the Netherlands.
All details including advanced scientific programme available on europdxworkshop.eu
See you there!
Emilie Vinolo retweeted
In loving memory of Dr. Baselga, a real visionary in the cancer field: theatlantic.com/sponsored/as…
Emilie Vinolo retweeted
Finally out! In this paper, published in @CRC_AACR,
first authored by Daniel Massó-Vallés, we show that MYC inhibition by Omomyc both prevents and halts disease progression in metastatic breast cancer. @VHIO and @peptomyc. Really proud of Daniel and team. teapaw.org/VHIO/status/1495671250…
Emilie Vinolo retweeted
It's time to ensure #RareCancers get the attention they deserve!
Thank you @wef for raising awareness on that essential topic with us.
WEF article: ow.ly/OMfF50HXHal
More on EORTC's work to tacle rare cancers: ow.ly/Isqw50HYqnT
#LeavingNoCancerPatientBehind
Emilie Vinolo retweeted
📣Do you want to help characterizing specific commonalities amongst a large group of “disregarded” rare diseases?
Apply for the new @irdirc Task Force!
🚨 Application deadline: 11 February
ℹ️More information: ejprarediseases.org/call-for…
ALT Apply for IRDiRC Task Force on Disregarded Rare Diseases
Emilie Vinolo retweeted
Phenomenal paper just published in Science persuasively demonstrating that EBV causes most if not all multiple sclerosis.
Phenomenal epidemiological design and technical achievement. 👏
science.org/doi/10.1126/scie…
Emilie Vinolo retweeted
Treatment landscape for pts with HER2+ mBC is rapidly evolving 📈
📢 check our review on how we treat
📌 just out @ESMO_Open
@myESMO @OncoAlert #bcsm
👉 tinyurl.com/HER2mBC – at Belgium
Emilie Vinolo retweeted
IT IS HAPPENING!! 🎇🎇🎇
Join us during the #HorizonEU #EUmissions Info-Days on 18 and 19 January!🗓️
You will find out everything about the 🆕 Missions’ Work Programme calls, funding opportunities and timelines 🇪🇺👩🔬
➡️ec.europa.eu/info/news/save-…
Emilie Vinolo retweeted
Cancer : des chercheurs de l’ULB découvrent le rôle essentiel d’une protéine dans la transition maligne de la maladie rtbf.be/info/societe/detail_…
Emilie Vinolo retweeted
Planning to generate a #novel genetically altered mouse strains for #BiomedicalResearch. Apply to the GEMM programme that provides the expertise and resources required to create and validate new and #innovative #mousemodels.
#Genetics #RareDiseases #CancerResearch
The GEMM call is now open. The MRC has committed resources to generating free novel genetically altered mouse strains to be used in vital biomedical research by the UK scientific community. Visit our website for all the relevant info and to apply. har.mrc.ac.uk/international-…
Emilie Vinolo retweeted
Are you working on #RareDiseases and would like to increase your methodological portfolio? Learn how #LifeSciences #ResearchInfrastructures like @InfrafrontierEU can boost your #research with #cuttingedge services 👉🏼 bit.ly/3aSYESt @ERICA_RD_EU #EU_RIs
On 8 Nov, Anton Ussi (@EatrisEric Operations & Finance Director) will be talking about the cutting edge resources & services provided by the EU Life Science #RIs for #RareDiseases.
👉 More here: eatris.eu/events/erica-webin… @LUMC_Leiden This webinar is organised by the ERICA Project
Emilie Vinolo retweeted
Pour les 30 ans de la Fête de la Science @FeteScience et l'« Année de la biologie au @CNRS», les unités de « Physico-Chimie » et de « Biologie Cellulaire et Cancer » de l'@institut_curie vous accueillent. Demandez le programme ! bit.ly/2ZJmga2
Emilie Vinolo retweeted
📣 Abrimos la primera convocatoria de becas institucionales para investigadores predoctorales. Únete a nuestro equipo❗️
➕ bit.ly/3usGT5B
#PhDFellowshipsCall
Emilie Vinolo retweeted
Our project manager @MauroPaschetta @unito presented @EurOPDD activities on #WorldCancerResearchDay in the frame of #EuropeanResearchersNight ! Such a great initiative!
The poster will be included on our website in its English and Italian versions.
@EU_H2020 #EDIReX #EU_RIs
#EurOPDX research infrastructure at the #europeanresearchersnight2021 to explain the importance of the PDX biobank in cancer research! #UNITO #EDIReX #Horizon2020
Emilie Vinolo retweeted
#ESMO21: Keynote lecture w/ @jsoriamd #Drugdevelopment: How can academia and industry work together 👇Today (19/9) 12:45—13:15 Channel 1 ow.ly/ms6G50GctlE
#ESMO21: @jsoriamd on how to bridge the gap between academia & industry. Shared interests, mutual gain, flexibility & trust key to building win–win partnerships in #drugdevelopment.
ESMO Daily Reporter 👉 ow.ly/1xUt50G8dNh
#clinicaltrial #cancerresearch #innovation
Emilie Vinolo retweeted
Exciting to see some of our work getting closer and closer to patients!! Thanks to @VIBLifeSciences for believing in this project from day 1 and their amazing support and resilience. Thanks also to @vib_ccb and @Onco_KULeuven
✨VIB spin-off Flamingo Therapeutics could be a game changer in cancer treatment with RNA-targeted approach. Start-up, based on @lab_marine (VIB @KU_Leuven) & @pieter_mestdagh (@crighent @ugent) research, announced strategic alliance with @ionispharma
👉 bit.ly/3ySaW7p
Emilie Vinolo retweeted
We’re calling on #pediatric & #raredisease communities to engage in a network with our #StakeholderForum and @CYBiobank tackling pediatric biobanking and its ethical, legal & societal challenges.
From 1-30 Sept:
bit.ly/3kIMAYt
#pediatricbiobanking #patientengagement
Emilie Vinolo retweeted
If you had to name one thing that had a huge positive impact on European patient advocacy, it would be #EUPATI, the European Patient Academy for Therapeutic Innovation. 🧵
EUPATI #Fellow #Feedback 👇 'If you want to get involved EUPATI is a huge benefit'. Explore our online courses and resources here🎓: bit.ly/OpenClassroomOverview
#GetInvolved #Patient #Education #StrongerTogether
